EAS 2015 — 83rd European Atherosclerosis Society Congress

EAS 2015 — 83rd European Atherosclerosis Society Congress
Change content default value

KEYNOTE SPEAKERS

Professor Børge Nordestgaard, Chief Physician in Clinical Biochemistry

Professor Børge Nordestgaard, Chief Physician in Clinical Biochemistry

******@***heh.regionh.dk

Professor - Copenhagen University Hospital
Doctor Christine Mummery, Chairman

Doctor Christine Mummery, Chairman

******@***lumc.nl

Professor - Leiden University Medical Center
MD, PhD Matthias Nahrendorf, Associate Professor

MD, PhD Matthias Nahrendorf, Associate Professor

******@***mgh.harvard.edu

Associate Professor - Harvard Medical School
Professor Martin Bennett, Professor of Cardiovascular Sciences

Professor Martin Bennett, Professor of Cardiovascular Sciences

******@***mole.bio.cam.ac.uk

Professor of Cardiovascular Sciences - University of Cambridge

Exhibit

Symposia

Workshops

Organiser

Sponsor



EAS 2015

Atherosclerosis and vascular disease research is a fast moving field and it is critical to keep up with the latest thinki​ng and developments. Join us in Glasgow to hear internationally renowned plenary speakers deliver expert views on current hot topics to participate in knowledge exchange in interactive workshops and poster sessions and to build your contacts and collaborations through congenial networking events. We look forward to welcoming you to Glasgow, one of Europe’s friendliest and liveliest cities for an exciting Congress.

Topics

TRACK 1 – VASCULAR BIOLOGY OF THE ARTERY WALL
  • STEM CELLS AND VASCULAR DISEASE
  • ​EPIGENETICS AND NON-CODING RNA IN VASCULAR BIOLOGY
  • ​​MICROVESSELS AND ANGIO-GENESIS IN ATHEROSCLEROSIS
  • MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS IN VASCULAR DISEASE​
TRACK 2 – LIPID AND LIPOPROTEIN METABOLISM
  • ​NOVEL REGULATORY MECHA-NISMS IN LIPID TRANSPORT
  • ​GENETIC REGULATION OF LIPID METABOLISM
  • FH AND SEVERE HYPERLIPIDEMIAS
  • NEW INSIGHTS INTO HDL FUNCTION
​TRACK 3 – RISK FACTORS, PREVENTION AND TREATMENT OF CVD
  • ​GENES AS RISK FACTORS FOR CVD
  • CVD PREDICTION AND NOVEL BIOMARKERS​
  • ​MICRONUTRIENTS AND VITAMINS IN POPULATION CVD HEALTH
  • LP(a) AND NOVEL LIPID TARGETS
TRACK 4 – ADVANCED CLINICAL SEMINARS
  • ​NOVEL STRATEGIES IN LIPID LOWERING AND ANTI-ATHERO-SCLEROSIS ​INTERVENTIONS
  • ​IMAGING ATHEROSCLEROSIS- DIAGNOSTIC AND PROGNOSTIC USES
  • THERAPEUTIC CHALLENGES IN STATIN INTOLERANCE AND SECONDARY DYSLIPIDEMIA
  • ​NEW METRICS AND MODELLING FOR CVD RISK PREDICTION

Register here

If you have recently become an EAS member, or paid your dues, please allow two working days for your membership to be processed by the Congress registration team.​​

For registration Click here



Related articles

More events

Interventional Complications 2024

Fri, 2 Aug 2024 - Sat, 3 Aug 2024


Pine Street 721
Seattle, 98101
United States
Echo/Imaging New York: State-of-the-Art 2024

Mon, 12 Aug 2024 - Wed, 14 Aug 2024


Broadway 1535
New York, New York 10036
United States